Related Experiment Video
Updated: Jul 10, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Hypertension in children with chronic kidney disease: pathophysiology and management
Charlotte Hadtstein1, Franz Schaefer
1Division of Pediatric Nephrology, Center for Pediatric and Adolescent Medicine, University Hospital of Heidelberg, Im Neuenheimer Feld 151, 69120, Heidelberg, Germany.
Insights
Children with chronic kidney disease (CKD) frequently develop arterial hypertension. Early screening and management, including non-pharmacological and pharmacological approaches, are crucial for better renal and cardiovascular outcomes in pediatric CKD patients.
Area of Science:
- Pediatric Nephrology
- Cardiovascular Health in Chronic Kidney Disease
Background:
- Arterial hypertension is highly prevalent across all stages of chronic kidney disease (CKD) in children.
- Established factors include fluid overload and renin-angiotensin system activation, with recent evidence highlighting sympathetic hyperactivation, endothelial dysfunction, and hyperparathyroidism.
- Medications commonly used in CKD (e.g., erythropoietin, glucocorticoids, cyclosporine A) can independently elevate blood pressure.
Purpose of the Study:
- To emphasize the critical need for active screening of hypertension in all pediatric CKD patients.
- To outline management strategies, prioritizing non-pharmacological interventions before initiating antihypertensive drug therapy.
- To underscore the importance of achieving blood pressure targets for improved renal and cardiovascular outcomes.
Main Methods:
- Review of pathophysiological mechanisms contributing to CKD-associated hypertension in children.
- Discussion of non-pharmacological interventions, including dietary modifications and dialysis adjustments (low salt, low dialysate sodium, optimized dry weight).
- Evaluation of first-line antihypertensive pharmacotherapies (ACE inhibitors, ARBs for proteinuria) and adjunctive therapies (diuretics).
Main Results:
- Non-pharmacological strategies, particularly in hemodialysis patients, can significantly aid blood pressure control.
- ACE inhibitors and ARBs are recommended for patients with proteinuria due to their dual benefits.
- Multiple antihypertensive medications are frequently necessary to achieve target blood pressure levels (below the 90th percentile).
Conclusions:
- Proactive hypertension screening and management are essential in pediatric CKD.
- A combination of lifestyle modifications and pharmacotherapy is often required for effective blood pressure control.
- Optimal blood pressure management is vital for mitigating CKD progression and reducing long-term cardiovascular risk.
Abstract:
Arterial hypertension is very common in children with all stages of chronic kidney disease (CKD). While fluid overload and activation of the renin-angiotensin system have long been recognized as crucial pathophysiological pathways, sympathetic hyperactivation, endothelial dysfunction and chronic hyperparathyroidism have more recently been identified as important factors contributing to CKD-associated hypertension. Moreover, several drugs commonly administered in CKD, such as erythropoietin, glucocorticoids and cyclosporine A, independently raise blood pressure in a dose-dependent fashion. Because of the deleterious consequences of hypertension on the progression of renal disease and cardiovascular outcomes, an active screening approach should be adapted in patients with all stages of CKD. Before one starts antihypertensive treatment, non-pharmacological options should be explored. In hemodialysis patients a low salt diet, low dialysate sodium and stricter dialysis towards dry weight can often achieve adequate blood pressure control. Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers are first-line therapy for patients with proteinuria, due to their additional anti-proteinuric properties. Diuretics are a useful alternative for non-proteinuric patients or as an add-on to renin-angiotensin system blockade. Multiple drug therapy is often needed to maintain blood pressure below the 90th percentile target, but adequate blood pressure control is essential for better renal and cardiovascular long-term outcomes.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease IV: Nursing Management
Hypertension and Regulation of Blood Pressure
Hypertension II: Pathophysiology
Chronic Kidney Disease II: Clinical Manifestations
